New study backs risk estimate for contraceptive pills



The broadest study of its kind on Wednesday backed estimates that newer kinds of contraceptive pills carry a higher risk of dangerous blood clots.

But it also confirmed past advice that the risk is very low in real terms and there was no immediate worry for women who take these pills.

The probe, published in the BMJ, compared oral contraceptives containing a synthetic version of the hormone progestogen with earlier versions of the pill.

The so-called third-generation pill, introduced in the 1990s, and the fourth generation, approved in the last decade, are designed to skirt side-effects of older types of the contraceptive.

In 2013, Europe’s drugs watchdog carried out a safety review after France’s medicines agency found the newer pills were linked to a small risk of serious blood clot called venous thrombo-embolism (VTE).

The new study widens the statistical net, trawling through two large British prescription databases to take into account pill dosage, body fat, smoking and other factors which affect risk.

Compared with women not using oral contraceptives, women using older pills had about two and a half times increased risk of VTE, it found.

Women using a newer version of the contraceptive had around a four times increased risk of VTE compared to women who did not take the pill.

Risks for women using newer pills were around 1.5 to 1.8 times higher than for women using older pills.

But in absolute terms, the risk was very low.

There were six extra VTE cases per year per 10,000 women using the newer levonorgestrel and norgestimate pills. This rose to 14 extra cases per 10,000 users of desogestrel and cyproterone.

The results concur with a French investigation in 2013 and a Danish study in 2011.

Women taking the later-generation contraceptives “should not stop using them, but should consult their doctor and review their current type of pill at their next appointment if there are any concerns,” said the researchers, led by Yana Vinogradova at the University of Nottingham.

After carrying out its own review, the European Medicines Agency (EMA) said in 2013 that the benefits of all types of contraceptive pill “continue to outweigh risks.”

“There is no reason for women who have been using (contraceptive pills) without any problem to stop taking them,” it said.

The EMA also reiterated advice to doctors to make regular assessments about the risk of blood clots to any patient taking contraceptive pills.



Agence France-Presse is a global news agency delivering fast, in-depth coverage of the events shaping our world from wars and conflicts to politics, sports, entertainment and the latest breakthroughs in health, science and technology.

  • mkenyamzalendo


  • Mwangalendo

    It is perhaps an indication of the changes in Kenya today when the presidential guards do not wreak havoc on demonstrators when a protest is in progress and compromises the security of the head of state and I shudder to think what may have been the outcome 13 months ago.

    Are these the stirrings of a rebellion the Mubarak way? When those who have sworn to uphold the constitution, the sovereignty of the land and to protect the people of Kenya appear to abdicate their responsibilities can you really blame them for demanding justice?? 

  • Gitundujeph

    taking that joke too far… eeeh that is putting the life of the HOS at risk….style up

  • Yderfy

    gitundu u nid to styl up uaself fast

You may also like...